UPClytics
View all cases

UPC CoA 120/2025

Feb 17, 2025·EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Case details
Status
Case Closed (Settled)
Action
Appeal
Category
Main appeal
Parties
Claimants
Representatives
Respondents
Representatives
Division
Court of Appeal
Technology
  • Instruments
    Medical technology
Language
English
First decided
Jun 5, 2025
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Judge Rian KaldenLocked
Judge Ingeborg SimonssonLocked
Judge Patricia RombachLocked
Judge Jeroen MeewisseLocked
Judge Stefan WilhelmLocked

At the UPC: Tandem Diabetes Care Group (18 cases)·Roche Group (29 cases)

This dispute contains 9 other proceedings

UPC CFI 11/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023·UPC APP 3514/2024 and 4 more

1 other defendants litigating the same or a related patent

UPC CFI 325/2024

Start a free trial to see how each one ended.

More cases: Court of Appeal·2025

Decisions
  • 2025-06-05
    Application RoP 365Public

    Summary: The Court of Appeal confirmed a settlement agreement between Tandem Diabetes and Roche Diabetes, terminating the appeal proceedings. The settlement arose after the Central Division Paris had dismissed the revocation action and maintained EP 2 196 231 as granted.

    Show the legal issues (4)
    • Settlement confirmation
    • R.365 RoP
    • Revocation action
    • Ambulatory drug infusion system
Document titleDatePublic
Headnote-and-Keywords2025-07-03Not public
Outcome of the Order2025-07-03Not public
Reimbursement of court fees2025-07-03Public
Receipt2025-06-26Not public
2025-06-24_CoA_Revocation_action_Application_reimbursement_court_fees_EP231_Tandem_signiert.pdf2025-06-24Not public
Case Closure Formal Check2025-06-06Not public
Outcome of the Order2025-06-05Not public
Settlement confirmation CONFIDENTIAL2025-06-05Not public
Settlement confirmation CONFIDENTIAL2025-06-05Public
Receipt2025-05-26Not public